Form 4: LeonaBio Director Acquires Stock Options

LeonaBio, Inc. director James A. Johnson acquired 28,000 stock options with an exercise price of $9.54, vesting over 24 months.

Summary

• Director James A. Johnson of LeonaBio, Inc. acquired 28,000 stock options on April 9, 2026.
• The options have an exercise price of $9.54 per share.
• These options are subject to a 24-month vesting schedule, with monthly vesting anniversaries.
• Vesting is contingent upon Mr. Johnson remaining a Service Provider as defined by the Issuer's 2026 Equity Incentive Plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents a standard compensation mechanism for a director, indicating continued engagement and potential belief in future company value.

Positives

• Director acquisition of stock options indicates confidence in the company's future prospects.
• The vesting schedule aligns the director's incentives with long-term company performance.

Risks

• The value of the stock options is subject to market fluctuations and the company's stock performance.
• Failure to remain a Service Provider for the full 24 months would result in forfeiture of unvested options.

Future Outlook

The stock options are exercisable over a 10-year period, expiring on April 8, 2036, with vesting occurring over the initial 24 months from the grant date.

Industry Context

StockSavvy.ai notes that the grant of stock options to a director is a common practice in the biotechnology sector to attract and retain key talent and align their interests with shareholders, especially during early-stage development or growth phases.

Stakeholder Impact

• Shareholders: The acquisition of options by a director can be seen as a positive signal of confidence, potentially influencing investor sentiment. However, the actual impact depends on the company's future performance.
• Employees: The existence of an equity incentive plan, as referenced, suggests a broader framework for employee compensation and retention, which can impact morale and productivity.

Next Steps

• The director will continue to vest in the stock options monthly over the next 24 months, provided they remain a Service Provider.
• The director may choose to exercise the vested options at any point up to the expiration date of April 8, 2036.

Key Dates

Keywords

Form 4, SEC Filing, Stock Options, Insider Trading, LeonaBio, LONA, Director, Equity Incentive Plan, Beneficial Ownership